Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-α and dexamethasone

Krishnaswamy G. Tirumurugaan, Bit N. Kang, Reynold A. Panettieri, Douglas N. Foster, Timothy F. Walseth, Mathur S. Kannan

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Background: CD38 is expressed in human airway smooth muscle (HASM) cells, regulates intracellular calcium, and its expression is augmented by tumor necrosis factor alpha (TNF-α). CD38 has a role in airway hyperresponsiveness, a hallmark of asthma, since deficient mice develop attenuated airway hyperresponsiveness compared to wild-type mice following intranasal challenges with cytokines such as IL-13 and TNF-α. Regulation of CD38 expression in HASM cells involves the transcription factor NF-κB, and glucocorticoids inhibit this expression through NF-κB-dependent and -independent mechanisms. In this study, we determined whether the transcriptional regulation of CD38 expression in HASM cells involves response elements within the promoter region of this gene.Methods: We cloned a putative 3 kb promoter fragment of the human cd38 gene into pGL3 basic vector in front of a luciferase reporter gene. Sequence analysis of the putative cd38 promoter region revealed one NF-κB and several AP-1 and glucocorticoid response element (GRE) motifs. HASM cells were transfected with the 3 kb promoter, a 1.8 kb truncated promoter that lacks the NF-κB and some of the AP-1 sites, or the promoter with mutations of the NF-κB and/or AP-1 sites. Using the electrophoretic mobility shift assays, we determined the binding of nuclear proteins to oligonucleotides encoding the putative cd38 NF-κB, AP-1, and GRE sites, and the specificity of this binding was confirmed by gel supershift analysis with appropriate antibodies.Results: TNF-α induced a two-fold activation of the 3 kb promoter following its transfection into HASM cells. In cells transfected with the 1.8 kb promoter or promoter constructs lacking NF-κB and/or AP-1 sites or in the presence of dexamethasone, there was no induction in the presence of TNF-α. The binding of nuclear proteins to oligonucleotides encoding the putative cd38 NF-κB site and some of the six AP-1 sites was increased by TNF-α, and to some of the putative cd38 GREs by dexamethasone.Conclusion: The EMSA results and the cd38 promoter-reporter assays confirm the functional role of NF-κB, AP-1 and GREs in the cd38 promoter in the transcriptional regulation of CD38.

Original languageEnglish (US)
Article number26
JournalRespiratory research
Volume9
DOIs
StatePublished - Mar 14 2008

Bibliographical note

Funding Information:
This study was supported by National Institutes of Health Grants HL-057498 (to M.S. Kannan), DA-11806 (to T.F. Walseth), HL-081824 and National Institute of Environmental Health Sciences (NIEHS) ES0135080 grants (to R.A. Panettieri), and a Grant-in-Aid from the University of Minnesota Graduate School (to M.S. Kannan).

Fingerprint

Dive into the research topics of 'Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-α and dexamethasone'. Together they form a unique fingerprint.

Cite this